BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2342073)

  • 21. Is thioredoxin the physiological vitamin K epoxide reducing agent?
    Preusch PC
    FEBS Lett; 1992 Jul; 305(3):257-9. PubMed ID: 1299627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
    Preusch PC; Smalley DM
    Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No strict coupling of vitamin K1 (2-methyl-3-phytyl-1,4-naphthoquinone)-dependent carboxylation and vitamin K1 epoxidation in detergent-solubilized microsomal fractions from rat liver.
    Wallin R
    Biochem J; 1979 Mar; 178(3):513-9. PubMed ID: 454361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
    Preusch PC; Suttie JW
    Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect inhibition of vitamin K epoxide reduction by salicylate.
    Hildebrandt E; Suttie JW
    J Pharm Pharmacol; 1984 Sep; 36(9):586-91. PubMed ID: 6149281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH; Janssen YP; Vervoort LT
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereospecificity of vitamin K-epoxide reductase.
    Preusch PC; Suttie JW
    J Biol Chem; 1983 Jan; 258(2):714-6. PubMed ID: 6822505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin K epoxide and quinone reductase activities. Evidence for reduction by a common enzyme.
    Gardill SL; Suttie JW
    Biochem Pharmacol; 1990 Sep; 40(5):1055-61. PubMed ID: 2390102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin K epoxide reductase: evidence that vitamin K dihydroquinone is a product of vitamin K epoxide reduction.
    Sherman PA; Sander EG
    Biochem Biophys Res Commun; 1981 Dec; 103(3):997-1005. PubMed ID: 7332587
    [No Abstract]   [Full Text] [Related]  

  • 35. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 36. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
    Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T
    Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver.
    Suttie JW; Preusch PC
    Haemostasis; 1986; 16(3-4):193-215. PubMed ID: 3530899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ; Principe LM; Fasco MJ
    Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; BĂ©langer PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of vitamin K1 2,3-epoxide in rat liver mitochondria.
    Inyangetor PT; Thierry-Palmer M
    Arch Biochem Biophys; 1988 May; 262(2):389-96. PubMed ID: 2835004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.